Durvalumab + Tremelimumab
Treatment used for 1 condition
Total Trials
6
Total Participants
5K
Avg Effectiveness
72%
Avg Safety Score
35%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 1 condition
Click on a condition to view detailed treatment information and clinical trial data.